The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
The Emerging Role of Innate Immunity in the Heart and Vascular System: For Whom the Cell Tolls
Open accessAbstract
Recent studies suggest that the heart possesses an innate immune system that is intended to delimit tissue injury, as well as orchestrate homoeostatic responses, within the heart. The extant literature suggests that this intrinsic stress response system is mediated, at least in part, by a family of pattern recognition receptors, most notably the Toll-like receptors. Although the innate immune system provides a short-term adaptive response to tissue injury, the beneficial effects of this phylogenetically ancient system may be lost if innate immune signaling becomes sustained and/or excessive; in which case, the salutary effects of activation of these pathways are contravened by the known deleterious effects of inflammatory signaling. Herein, the biology of innate immune signaling in the heart is reviewed, as well as the literature suggesting that the innate immune system is involved in the pathogenesis of atherosclerosis, acute coronary syndromes, stroke, viral myocarditis, sepsis, ischemia/reperfusion injury, and heart failure. The review concludes by discussing new therapies that are being developed to modulate the innate immune system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
Medzhitov, R., Preston-Hurlburt, P., & Janeway, C. A. (1997) · Nature · doi:10.1038/41131 · Cited by 5,590
Taganov, K. D., Boldin, M. P., Chang, K.-J., & Baltimore, D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605298103 · Cited by 4,317
DAMPs, PAMPs and alarmins: all we need to know about danger
Bianchi, M. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0306164 · Cited by 2,794
What is principal component analysis?
Ringnér, M. (2008) · Nature Biotechnology · doi:10.1038/nbt0308-303 · Cited by 2,407
Inflammation in Atherosclerosis
Libby, P., Ridker, P. M., & Hansson, G. K. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.09.009 · Cited by 2,228
Saikku, P., Mattila, K., Nieminen, M. S., Huttunen, J. K., Leinonen, M., Ekman, M.-R., Mäkelä, P. H., & Valtonen, V (1988) · The Lancet · doi:10.1016/s0140-6736(88)90741-6 · Cited by 1,964
Chung, E. S., Packer, M., Lo, K. H., Fasanmade, A. A., & Willerson, J. T. (2003) · Circulation · doi:10.1161/01.cir.0000077913.60364.d2 · Cited by 1,644
Inferences, questions and possibilities in Toll-like receptor signalling
Beutler, B. (2004) · Nature · doi:10.1038/nature02761 · Cited by 1,466
IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling
Kobayashi, K., Hernandez, L. D., Galán, J. E., Janeway, C. A., Medzhitov, R., & Flavell, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00827-9 · Cited by 1,286
Mann, D. L., McMurray, J. J. V., Packer, M., Swedberg, K., Borer, J. S., Colucci, W. S., Djian, J., Drexler, H., Feldman, A., Kober, L., et al. (2004) · Circulation · doi:10.1161/01.cir.0000124490.27666.b2 · Cited by 1,240
Self-citationDanger signals: SOS to the immune system
Gallucci, S., & Matzinger, P. (2001) · Current Opinion in Immunology · doi:10.1016/s0952-7915(00)00191-6 · Cited by 1,204
Toll-like Receptor 4 Polymorphisms and Atherogenesis
Kiechl, S., Lorenz, E., Reindl, M., Wiedermann, C. J., Oberhollenzer, F., Bonora, E., Willeit, J., & Schwartz, D. A. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012673 · Cited by 1,024
Michelsen, K. S., Wong, M. H., Shah, P. K., Zhang, W., Yano, J., Doherty, T. M., Akira, S., Rajavashisth, T. B., & Arditi, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403249101 · Cited by 1,019
Sheedy, F. J., Palsson-McDermott, E., Hennessy, E. J., Martin, C., O'Leary, J. J., Ruan, Q., Johnson, D. S., Chen, Y., & O'Neill, L. A. J. (2010) · Nature Immunology · doi:10.1038/ni.1828 · Cited by 1,005
Inflammatory Mediators and the Failing Heart: Past, Present, and the Foreseeable Future
Mann, D. L. (2002) · Circulation Research · doi:10.1161/01.res.0000043825.01705.1b · Cited by 988
Self-citationTargeting Toll-like receptors: emerging therapeutics?
Hennessy, E. J., Parker, A. E., & O'Neill, L. A. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3203 · Cited by 886
Inositol phosphatase SHIP1 is a primary target of miR-155
O'Connell, R. M., Chaudhuri, A. A., Rao, D. S., & Baltimore, D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902636106 · Cited by 826
Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium
Frantz, S., Kobzik, L., Kim, Y.-D., Fukazawa, R., Medzhitov, R., Lee, R. T., & Kelly, R. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6709 · Cited by 645
Reduced Myocardial Ischemia-Reperfusion Injury in Toll-Like Receptor 4-Deficient Mice
Oyama, J.-I., Blais, C., Liu, X., Pu, M., Kobzik, L., Kelly, R. A., & Bourcier, T. (2004) · Circulation · doi:10.1161/01.cir.0000112575.66565.84 · Cited by 621
Modulation of atherosclerosis in mice by Toll-like receptor 2
Mullick, A. E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25482 · Cited by 549
Carty, M., Goodbody, R., Schröder, M., Stack, J., Moynagh, P. N., & Bowie, A. G. (2006) · Nature Immunology · doi:10.1038/ni1382 · Cited by 539
Tissue-Specific mRNA Expression Profiles of Human Toll-Like Receptors and Related Genes
Nishimura, M., & Naito, S. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.886 · Cited by 443
Azithromycin for the Secondary Prevention of Coronary Events
Grayston, J. T., Kronmal, R. A., Jackson, L. A., Parisi, A. F., Muhlestein, J. B., Cohen, J. D., Rogers, W. J., Crouse, J. R., Borrowdale, S. L., Schron, E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043526 · Cited by 375
Arslan, F., Smeets, M. B., O'Neill, L. A. J., Keogh, B., McGuirk, P., Timmers, L., Tersteeg, C., Hoefer, I. E., Doevendans, P. A., Pasterkamp, G., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.880187 · Cited by 358
A Prospective, Randomized, Controlled Trial of Prednisone for Dilated Cardiomyopathy
Parrillo, J. E., Cunnion, R. E., Epstein, S. E., Parker, M. M., Suffredini, A. F., Brenner, M., Schaer, G. L., Palmeri, S. T., Cannon, R. O., Alling, D., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198910193211601 · Cited by 353
Signaling pathways in ischemic preconditioning
Downey, J. M., Davis, A. M., & Cohen, M. V. (2007) · Heart Failure Reviews · doi:10.1007/s10741-007-9025-2 · Cited by 319
Mechanisms of Disease: Toll-like receptors in cardiovascular disease
Frantz, S., Ertl, G., & Bauersachs, J. (2007) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio0938 · Cited by 312
LPS-Induced Upregulation of SHIP Is Essential for Endotoxin Tolerance
Sly, L. M., Rauh, M. J., Kalesnikoff, J., Song, C. H., & Krystal, G. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.010 · Cited by 306
Toll-Like Receptor-2 Modulates Ventricular Remodeling After Myocardial Infarction
Shishido, T., Nozaki, N., Yamaguchi, S., Shibata, Y., Nitobe, J., Miyamoto, T., Takahashi, H., Arimoto, T., Maeda, K., Yamakawa, M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000101921.93016.1c · Cited by 303
Antibiotic Treatment of Chlamydia pneumoniae after Acute Coronary Syndrome
Cannon, C. P., Braunwald, E., McCabe, C. H., Grayston, J. T., Muhlestein, B., Giugliano, R. P., Cairns, R., & Skene, A. M. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043528 · Cited by 291
Inhibition of Toll-like Receptor 4 With Eritoran Attenuates Myocardial Ischemia-Reperfusion Injury
Shimamoto, A., Chong, A. J., Yada, M., Shomura, S., Takayama, H., Fleisig, A. J., Agnew, M. L., Hampton, C. R., Rothnie, C. L., Spring, D. J., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.000901 · Cited by 284
Deleterious effects of methylprednisolone in patients with myocardial infarction.
Roberts, R. E., deMELLO, V. R., & Be, S. (1976) · PubMed · Cited by 277
The Emerging Role of MicroRNAs in Cardiac Remodeling and Heart Failure
Divakaran, V., & Mann, D. L. (2008) · Circulation Research · doi:10.1161/circresaha.108.183087 · Cited by 267
Self-citationRole of TLR-2 in the Activation of Nuclear Factor κB by Oxidative Stress in Cardiac Myocytes
Frantz, S., Kelly, R. A., & Bourcier, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009160200 · Cited by 266
Brown, J. M., Grosso, M. A., Terada, L. S., Whitman, G. J., Banerjee, A., White, C. W., Harken, A. H., & Repine, J. E. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2516 · Cited by 260
Toll-like receptor signaling in endogenous neuroprotection and stroke
Marsh, B. J., Williams-Karnesky, R. L., & Stenzel-Poore, M. P. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.067 · Cited by 255
Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart
Chao, W. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00995.2008 · Cited by 245
Introduction: The role of innate immunity in the adaptive immune response
Janeway Jr., C. A., & Medzhitov, R. (1998) · Seminars in Immunology · doi:10.1006/smim.1998.0142 · Cited by 243
Association of the Toll-Like Receptor 4 Gene Asp299Gly Polymorphism With Acute Coronary Events
Ameziane, N., Beillat, T., Verpillat, P., Chollet-Martin, S., Aumont, M.-C., Seknadji, P., Lamotte, M., Lebret, D., Ollivier, V., & de Prost, D. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000101191.92392.1d · Cited by 241
Boekholdt, S. M., Agema, W. R. P., Peters, R. J. G., Zwinderman, A. H., van der Wall, E. E., Reitsma, P. H., Kastelein, J. J. P., & Jukema, J. W. (2003) · Circulation · doi:10.1161/01.cir.0000068311.40161.28 · Cited by 225
Toll-like receptor 4 mediates ischemia/reperfusion injury of the heart
Chong, A. J., Shimamoto, A., Hampton, C. R., Takayama, H., Spring, D. J., Rothnie, C. L., Yada, M., Pohlman, T. H., & Verrier, E. D. (2004) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2003.11.036 · Cited by 222
Negishi, H., Osawa, T., Ogami, K., Ouyang, X., Sakaguchi, S., Koshiba, R., Yanai, H., Seko, Y., Shitara, H., Bishop, K., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810372105 · Cited by 221
Baumgarten, G., Knuefermann, P., Nozaki, N., Sivasubramanian, N., Mann, D. L., & Vallejo, J. G. (2001) · The Journal of Infectious Diseases · doi:10.1086/320712 · Cited by 212
Self-citationToll-Like Receptor 4 Is Involved in Outward Arterial Remodeling
Hollestelle, S. C. G., de Vries, M. R., van Keulen, J. K., Schoneveld, A. H., Vink, A., Strijder, C. F., van Middelaar, B. J., Pasterkamp, G., Quax, P. H. A., & de Kleijn, D. P. V. (2004) · Circulation · doi:10.1161/01.cir.0000109140.51366.72 · Cited by 197
Fuse, K., Chan, G., Liu, Y., Gudgeon, P., Husain, M., Chen, M., Yeh, W.-C., Akira, S., & Liu, P. P. (2005) · Circulation · doi:10.1161/circulationaha.105.536433 · Cited by 181
Hardarson, H. S., Baker, J. S., Yang, Z., Purevjav, E., Huang, C.-H., Alexopoulou, L., Li, N., Flavell, R. A., Bowles, N. E., & Vallejo, J. G. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00398.2006 · Cited by 177
Immune Cell Toll-Like Receptor 4 Is Required for Cardiac Myocyte Impairment During Endotoxemia
Tavener, S. A., Long, E. M., Robbins, S. M., McRae, K. M., Remmen, H. V., & Kubes, P. (2004) · Circulation Research · doi:10.1161/01.res.0000144175.70140.8c · Cited by 171
Unexpected protective role for Toll-like receptor 3 in the arterial wall
Cole, J. E., Navin, T. J., Cross, A. J., Goddard, M. E., Alexopoulou, L., Mitra, A. T., Davies, A. H., Flavell, R. A., Feldmann, M., & Monaco, C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018515108 · Cited by 170
Escherichia coli LPS-induced LV dysfunction: role of toll-like receptor-4 in the adult heart
Nemoto, S., Vallejo, J. G., Knuefermann, P., Misra, A., Defreitas, G., Carabello, B. A., & Mann, D. L. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00763.2001 · Cited by 166
Self-citationAssociation of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction*1
EDFELDT, K. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.05.004 · Cited by 164
Fallach, R., Shainberg, A., Avlas, O., Fainblut, M., Chepurko, Y., Porat, E., & Hochhauser, E. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.02.020 · Cited by 141
Riad, A., Jäger, S., Sobirey, M., Escher, F., Yaulema-Riss, A., Westermann, D., Karatas, A., Heimesaat, M. M., Bereswill, S., Dragun, D., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.10.6954 · Cited by 132
Letter: Pacing the WPW patient.
Goldstein, S. (1976) · Circulation · doi:10.1161/01.cir.53.1.204 · Cited by 128
Toll-like receptor 2 modulates left ventricular function following ischemia-reperfusion injury
Sakata, Y., Dong, J.-W., Vallejo, J. G., Huang, C., Baker, J. S., Tracey, K. J., Tacheuchi, O., Akira, S., & Mann, D. L. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00642.2006 · Cited by 122
Self-citationTOLL-LIKE RECEPTOR 4, NITRIC OXIDE, AND MYOCARDIAL DEPRESSION IN ENDOTOXEMIA
Baumgarten, G., Knuefermann, P., Schuhmacher, G., Vervölgyi, V., von Rappard, J., Dreiner, U., Fink, K., Djoufack, P. C., Hoeft, A., Grohé, C., et al. (2005) · Shock · doi:10.1097/01.shk.0000196498.57306.a6 · Cited by 119
Feng, Y., Zhao, H., Xu, X., Buys, E. S., Raher, M. J., Bopassa, J. C., Thibault, H., Scherrer‐Crosbie, M., Schmidt, U. H., & Chao, W. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00119.2008 · Cited by 107
Knuefermann, P., Sakata, Y., Baker, J. S., Huang, C., Sekiguchi, K., Harðarson, H. S., Takeuchi, O., Akira, S., & Vallejo, J. G. (2004) · Circulation · doi:10.1161/01.cir.0000143081.13042.04 · Cited by 105
Birks, E. J., Felkin, L. E., Banner, N. R., Khaghani, A., Barton, P. J. R., & Yacoub, M. H. (2004) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(03)00106-2 · Cited by 103
TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis
Yang, I. A. (2003) · Atherosclerosis · doi:10.1016/s0021-9150(03)00286-7 · Cited by 101
Lin, Y.-C., Chang, Y.-M., Yu, J.-M., Yen, J., Chang, J., & Hu, C. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.022 · Cited by 101
Knuefermann, P., Schwederski, M., Velten, M., Krings, P., Ehrentraut, H., Rüdiger, M., Boehm, O., Fink, K., Dreiner, U., Grohé, C., et al. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn011 · Cited by 90
Variation in the toll-like receptor 4 gene and susceptibility to myocardial infarction
Holloway, J. W., Yang, I. A., & Ye, S. (2005) · Pharmacogenetics and Genomics · doi:10.1097/01213011-200501000-00003 · Cited by 85
A frequent toll-like receptor (TLR)-2 polymorphism is a risk factor for coronary restenosis
Hamann, L., Gomma, A., Schröder, N. W. J., Stamme, C., Glaeser, C., Schulz, S., Gross, M. C., Anker, S. D., Fox, K. M., & Schumann, R. R. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-005-0643-7 · Cited by 85
on behalf of the PRIME Study group, Morange, P., Tiret, L., Saut, N., Luc, G., Arveiler, D., Ferrières, J., Amouyel, P., Evans, A., Ducimetière, P., et al. (2004) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201277 · Cited by 82
Norata, G. D., Garlaschelli, K., Ongari, M., Raselli, S., Grigore, L., Benvenuto, F., Maggi, F. M., & Catapano, A. L. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01509.x · Cited by 81
Endogenous Inflammatory Molecules Engage Toll-Like Receptors in Cardiovascular Disease
Ionita, M. G., Arslan, F., de Kleijn, D. P. V., & Pasterkamp, G. (2010) · Journal of Innate Immunity · doi:10.1159/000314270 · Cited by 81
Koch, W., Hoppmann, P., Pfeufer, A., Schömig, A., & Kastrati, A. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl231 · Cited by 76
IRAK1 deletion disrupts cardiac Toll/IL-1 signaling and protects against contractile dysfunction
Thomas, J. A., Haudek, S. B., Köroğlu, T., Tsen, M. F., Bryant, D. D., White, D. J., Kusewitt, D. F., Horton, J. W., & Giroir, B. P. (2003) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.0655.2001 · Cited by 74
Toll-like receptor 4 deficiency: Smaller infarcts, but nogain in function
Kim, S.-C., Ghanem, A., Stapel, H., Tiemann, K., Knuefermann, P., Hoeft, A., Meyer, R., Grohé, C., Knowlton, A. A., & Baumgarten, G. (2007) · BMC Physiology · doi:10.1186/1472-6793-7-5 · Cited by 73
MyD88 and NOS2 are essential for Toll-like receptor 4-mediated survival effect in cardiomyocytes
Zhu, X., Zhao, H., Graveline, A. R., Buys, E. S., Schmidt, U. H., Bloch, K. D., Rosenzweig, A., & Chao, W. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00112.2006 · Cited by 72
Netea, M. G., Hijmans, A., van Wissen, S., Smilde, T. J., Trip, M. D., Kullberg, B. J., de Boo, T., van der Meer, J. W. M., Kastelein, J. J. P., & Stalenhorf, A. F. H. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01303.x · Cited by 67
Toll-like Receptor 4 Asp299Gly Gene Polymorphism and Risk of Atherothrombosis
Zee, R. Y. L., Hegener, H. H., Gould, J. L., & Ridker, P. M. (2004) · Stroke · doi:10.1161/01.str.0000149948.31879.f0 · Cited by 66
Complement and Dilated Cardiomyopathy
Zwaka, T. P., Manolov, D., Özdemir, C., Marx, N., Kaya, Z., Kochs, M., Höher, M., Hombach, V., & Torzewski, J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64201-0 · Cited by 66
Innate immunity in the adult mammalian heart: for whom the cell tolls.
Mann, D. L., Topkara, V. K., Evans, S., & Barger, P. M. (2010) · PubMed · Cited by 65
Self-citationChang, Y.-C., Kao, W., Wang, W.-Y., Wang, W., Yang, R., & Peck, K. (2009) · The FASEB Journal · doi:10.1096/fj.09-129312 · Cited by 59
Toll Receptor Polymorphisms and Carotid Artery Intima-Media Thickness
Labrum, R. W., Bevan, S., Sitzer, M., Lorenz, M., & Markus, H. S. (2007) · Stroke · doi:10.1161/01.str.0000260184.85257.2b · Cited by 56
Toll-like Receptor Polymorphisms and Carotid Artery Intima-Media Thickness
Lepper, P. M., von Eynatten, M., Humpert, P. M., Triantafilou, M., & Triantafilou, K. (2007) · Stroke · doi:10.1161/strokeaha.107.487058 · Cited by 53
Dong, J.-W., Vallejo, J. G., Tzeng, H.-P., Thomas, J. A., & Mann, D. L. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00306.2009 · Cited by 49
Self-citationTherapeutic targeting of innate immunity in the failing heart
Topkara, V. K., Evans, S., Zhang, W., Epelman, S., Staloch, L. J., Barger, P. M., & Mann, D. L. (2010) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.11.003 · Cited by 48
Self-citationTLR signaling and trapped vascular dendritic cells in the development of atherosclerosis
Doherty, T. M., Fisher, E. A. A., & Arditi, M. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.03.006 · Cited by 47
Contribution of TLR7 and TLR9 signaling to the susceptibility of MyD88-deficient mice to myocarditis
Pagni, P. P., Traub, S., Demaria, O., Chasson, L., & Alexopoulou, L. (2010) · Autoimmunity · doi:10.3109/08916930903509056 · Cited by 40
Cited by
The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis
Prabhu, S. D., & Frangogiannis, N. G. (2016) · Circulation Research · doi:10.1161/circresaha.116.303577 · Cited by 2,224
Regulation of the Inflammatory Response in Cardiac Repair
Frangogiannis, N. G. (2012) · Circulation Research · doi:10.1161/circresaha.111.243162 · Cited by 1,194
Inflammation and atherosclerosis: signaling pathways and therapeutic intervention
Kong, P., Cui, Z.-Y., Huang, X.-F., Zhang, D.-D., Guo, R.-J., & Han, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00955-7 · Cited by 1,183
Reappraising the role of inflammation in heart failure
Adamo, L., Rocha-Resende, C., Prabhu, S. D., & Mann, D. L. (2020) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0315-x · Cited by 765
Self-citationMurphy, S. P., Kakkar, R., McCarthy, C. P., & Januzzi, J. L. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.01.014 · Cited by 738
Metadata
- Authors
- Mann, D. L.
- Venue
- Circulation Research
- Published
- 2011-04-29
- Volume
- 108
- Issue
- 9
- Pages
- 1133-1145
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W1987976516
- Cited by
- 365
- References
- 82
- FWCI
- 12.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.